3SH-96701-66164
2 vaccinations
5 coded responses
30 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 334 / FL
- Registered
- 2021-03-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-08
Registered in v-safe
-
2021-03-08
Dose 1 — Janssen/Johnson & Johnson
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-14
- 2021-03-15
- 2021-03-22
- 2021-03-29
- 2021-04-05
- 2021-04-12
- 2021-04-19
- 2021-06-07
- 2021-09-06
-
2021-11-20
Dose 2 — Pfizer-BioNTech
- 2021-11-20
-
2021-11-21
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2021-11-22
Survey response — days 1–6 daily, dose 2MedDRA: Asthma, Eczema, Pre-existing disease — Feeling: GoodFree text: Flare up of asthma and eczemaMedDRA releases: 2024-11 · check-in free text available
-
2021-11-23
Survey response — days 1–6 daily, dose 2MedDRA: Condition aggravated, Cough variant asthma, Eczema, Pre-existing disease — Feeling: Poor · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Asthmatic cough / eczema and non allergenic sinusitis acting upMedDRA releases: 2024-11 · check-in free text available
-
2021-11-24
Survey response — days 1–6 daily, dose 2MedDRA: Asthma, Eczema, Irritable bowel syndrome, Rhinitis — Feeling: Fair · Fever · Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to work or attend schoolFree text: IBS symptoms, asthma/eczema and non allergenic rhinitis still present but not as bad as MondayMedDRA releases: 2024-11 · check-in free text available
- 2021-11-25
- 2021-11-27
- 2021-12-04
- 2021-12-11
- 2021-12-18
- 2021-12-25
- 2022-01-01
-
2022-02-19
Survey response — 3 months, dose 2MedDRA: Heavy menstrual bleeding — Feeling: Good · Be unable to do your normal daily activitiesFree text: Extremely heavy periods / men steal bleeding and for a lot longer than usual. I just realized this has been happening since November 21MedDRA releases: 2024-11 · check-in free text available
-
2022-05-21
Survey response — 6 months, dose 2MedDRA: Heavy menstrual bleeding, Polypectomy, Uterine dilation and curettage, Uterine polyp — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Uterine polyps- heavy menses · Healthcare visit (other): Outpatient polyp e Romy and D and cMedDRA releases: 2024-11 · check-in free text available
-
2022-05-21
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-05-23
-
2022-05-23
Call successfulParticipant prefers to complete VAERS report online
- 2022-11-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-08 | Janssen/Johnson & Johnson | |
| 2 | 2021-11-20 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-05-21 | Successful 2022-05-23 |
Participant prefers to complete VAERS report online |
Free text
Release 10 — days 1–6 daily, dose 2
Systemic reaction (other): Flare up of asthma and eczema
Systemic reaction (other): Asthmatic cough / eczema and non allergenic sinusitis acting up
Systemic reaction (other): IBS symptoms, asthma/eczema and non allergenic rhinitis still present but not as bad as Monday
Release 11 — 3 months, dose 2
Symptoms: Extremely heavy periods / men steal bleeding and for a lot longer than usual. I just realized this has been happening since November 21
Release 11 — 6 months, dose 2
Symptoms: Uterine polyps- heavy menses
Healthcare visit (other): Outpatient polyp e Romy and D and c
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Polypectomy | · | · | ✓ |
| HCVO | Uterine dilation and curettage | · | · | ✓ |
| SD | Heavy menstrual bleeding | · | · | ✓ |
| SD | Uterine polyp | · | · | ✓ |
| SRO | Asthma | · | · | ✓ |
| SRO | Condition aggravated | · | · | ✓ |
| SRO | Cough variant asthma | · | · | ✓ |
| SRO | Eczema | · | · | ✓ |
| SRO | Irritable bowel syndrome | · | · | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
| SRO | Rhinitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release